moderna - Search News

Order byBest matchMost fresh

FDA Just Approved a New Covid Vaccine

FDA grants limited approval to new Covid vaccine from Moderna

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 and older, as well as people ages 12 to 64 with at least one medical condition that increases their risk for severe Covid.

· 1d

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

· 9h · on MSN

FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions

· 1d

FDA approves Moderna’s new lower-dose COVID-19 vaccine

The approval “adds an important new tool to help protect people at high risk of severe disease from COVID-19,” Stephane Bancel, Moderna’s CEO, said in a statement Saturday.

· 1d

US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older

Axios · 1d

FDA approves new Moderna COVID-19 vaccine

3don MSN

Trump administration yanks Moderna's bird flu vaccine research funding even as company reports promising test results

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

4don MSN

HHS cancels $590 million contract with Moderna for bird flu vaccine

The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to protect against bird flu amid the agency’s broader efforts to reevaluate therapies that use mRNA technology.

Moderna Announces Update on Investigational Pandemic Influenza Program

H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines CAMBRIDGE, MA / ACCESS Newswire / May 28,

U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine

Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the company’s shot.

FDA approves Moderna’s next-generation COVID vaccine for adults 65 or older

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

Explore more

Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services terminated a contract with drugmaker Moderna to develop an mRNA bird flu vaccine,